Research News

  • Nelson Delivers NIH Director’s Wednesday Afternoon Lecture
    Internationally recognized cerebral blood flow expert and University of Vermont Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., delivered a National Institutes of Health (NIH) Director’s Wednesday Afternoon Lecture, titled “Translating Thought into Blood Flow in the Brain: Capillaries as Sensors of Neural Activity,” on October 14.
  • Botten, Bruce & Colleagues' Study Describes Streamlined COVID-19 Test
    A team of scientists at the University of Vermont, working in partnership with a group at the University of Washington, has developed a method of testing for the COVID-19 virus that doesn’t make use of these chemicals but still delivers an accurate result, paving the way for inexpensive, widely available testing in both developing countries and industrialized nations like the United States, where reagent supplies are again in short supply.
  • UVM & VT United Ways Survey Puts Health Priority-Setting in Hands of Community
    Vermont United Ways and the Larner College of Medicine at the University of Vermont are providing Vermonters with a say in prioritizing community health needs via a survey that is the largest and most comprehensive public health project ever conducted by UVM medical students.
  • New $5.4 Million NIH Grant Funds UVM Center for Biomedical Shared Resources ​
    A new $5.47 million grant from the National Institutes of Health (NIH) to the University of Vermont Larner College of Medicine will support the creation of the UVM Center for Biomedical Shared Resources. The grant will fund completion of the Center's home on the first floor of the new Firestone Medical Research Building, which will be located on the south end of the Larner College of Medicine complex.
  • Plante Appointed Bloomfield Professor
    Timothy Plante ’06 M.D.’10, M.H.S., assistant professor of medicine, has been appointed the Martin E. Bloomfield ’56 M.D.’60 and Judith S. Bloomfield ’59 Early Career Professor in Cardiovascular Research at the University of Vermont’s Larner College of Medicine.
  • Larner Team Plays Role in NIH COVID-19 Blood Clotting Treatment Trials
    The University of Vermont (UVM) is participating in a major national research effort to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed and hospitalized with COVID-19—the disease caused by SARS-CoV-2.
  • Memorial Sloan Kettering’s Brentjens Delivers 5th Annual Stetson Lecture
    Renier Brentjens, M.D., Ph.D., director of cellular therapeutics in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, presented the 5th Annual Stetson Lecture in Technological Advances in Medicine via Zoom on September 8. He discussed “CARs and Armored CARs: Improving CAR T Cell Therapy for Cancer.”
  • Raszka in Wall Street Journal, CBS6 Albany Stories on COVID-19 and Children
    (AUGUST 10 & 12, 2020) Professor of Pediatrics William Raszka, M.D., was quoted in an August 10 Wall Street Journal article, titled “Latest Research Points to Children Carrying, Transmitting Coronavirus” CBS6 Albany story, titled "Spike in COVID-19 cases in children nationally, a pediatrics professor explains why."
  • Larner Grants Lead in Record-Setting Year for UVM Research Funding
    The University of Vermont received $181.7 million in research funding during the 2020 fiscal year - the largest in UVM history by a wide margin. The Larner College of Medicine had the largest number of grants.
  • Sigmon Listed in Fast Company's "Most Creative People in Business" for 2020
    (AUGUST 4, 2020) Associate Professor of Psychiatry Stacey Sigmon, Ph.D., is featured in the September 2020 issue of Fast Company as one of the 74 “Most Creative People in Business for 2020.” Sigmon is featured under the category of "For Designing A Superior Solution" for her work developing new models of opioid treatment delivery.